To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
Clinical trial NCT04311515 · TERMINATED
Trial details
- NCT number
- NCT04311515
- Sponsor
- Samus Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2020-09-09
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.